跳轉至內容
Merck
  • Determinants of anterior chamber angle narrowing after mydriasis in the patients with cataract.

Determinants of anterior chamber angle narrowing after mydriasis in the patients with cataract.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2014-10-15)
Shogo Arimura, Yoshihiro Takamura, Yuji Takihara, Takehiro Matsumura, Takeshi Tomomatsu, Masaru Inatani
摘要

To identify the determinants of anterior chamber angle narrowing after mydriasis by quantitative assessment of the anterior chamber components using anterior segment optical coherence tomography (AS-OCT). In this intervention study, anterior chamber angle analysis was performed using AS-OCT in patients with cataract before pharmacological pupillary dilation and 30 min afterwards. Angle narrowing was quantified by the change of angle opening distance 500 after mydriasis (ΔAOD500). Multivariate linear regression and stepwise selection regression were used to identify which parameters in AS-OCT significantly determined ΔAOD500. One hundred and two Japanese patients (age, mean ± standard deviation, 71.9 ± 11.2 years) were enrolled. Multivariate analysis indicated that smaller ΔAOD500 were significantly associated with larger lens vault (LV; P < 0.001), larger iris area (IA; P = 0.003), and posterior corneal arch distance (PCAL; P = 0.01). Stepwise linear regression analysis revealed that smaller ΔAOD500 was independently associated with larger LV (partial R (2) = 0.232, P < 0.001), larger IA (partial R (2) = 0.080, P = 0.001), and smaller PCAL (partial R (2) = 0.066, P = 0.002) before mydriasis. These three factors explained 37.7 % of the decrease in ΔAOD500. Larger LV, larger IA, and smaller PCAL contribute considerably to anterior chamber angle narrowing after mydriasis in patients with cataract.

材料
產品編號
品牌
產品描述

USP
去氧肾上腺素 盐酸盐, United States Pharmacopeia (USP) Reference Standard
Supelco
去氧肾上腺素, Pharmaceutical Secondary Standard; Certified Reference Material
去氧肾上腺素 盐酸盐, European Pharmacopoeia (EP) Reference Standard
去氧肾上腺素, European Pharmacopoeia (EP) Reference Standard
托吡卡胺, European Pharmacopoeia (EP) Reference Standard